首页>
外国专利>
Recombinant Adenovirus with Enhanced Tumoricidal Effect and Pharmaceutical Composition Comprising the Same
Recombinant Adenovirus with Enhanced Tumoricidal Effect and Pharmaceutical Composition Comprising the Same
展开▼
机译:具有增强的杀伤作用的重组腺病毒和包含该重组腺病毒的药物组合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
PURPOSE: A recombinant adenovirus having improved tumor killing effect and a pharmaceutical composition containing the same are provided. Therefore, a larger amount of genes are effectively transferred by administering a smaller amount of the recombinant adenovirus. CONSTITUTION: A recombinant adenovirus consists of adenovirus and protein containing VSV-G epitope derived from vesicular stomatitis virus which is connected to the adenovirus, wherein the adenovirus is YKL-1(KFCC-11099) or YKC-1(KFCC-11280); the VSV-G epitope connected region is adenovirus fiber knob region; the adenovirus fiber knob region is HI loop, pentone base or fiber terminal region; the VSV-G epitope has the amino acid sequence of SEQ ID NO: 3; a linker is inserted between the adenovirus fiber and VSV-G epitope; the linker consists of one or more glycines; and the recombinant adenovirus is YCI-Ad-VSVG(KFCC-11215).
展开▼
机译:用途:提供了具有改善的肿瘤杀伤作用的重组腺病毒和包含其的药物组合物。因此,通过施用较少量的重组腺病毒可有效转移大量基因。组成:重组腺病毒由腺病毒和含有与腺病毒相连的水泡性口炎病毒衍生的VSV-G表位的蛋白质组成,其中腺病毒为YKL-1(KFCC-11099)或YKC-1(KFCC-11280); VSV-G表位连接区为腺病毒纤维瘤区。腺病毒纤维瘤区域为HI环,戊酮基或纤维末端区域。 VSV-G表位的氨基酸序列为SEQ ID NO:3;在腺病毒纤维和VSV-G表位之间插入接头。接头由一种或多种甘氨酸组成;重组腺病毒为YCI-Ad-VSVG(KFCC-11215)。
展开▼